Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:02 PM ET 10-Q
Financial Results Ewsb Bancorp, Inc. EWSB

Ewsb Bancorp Q3 2026 Results: Net Loss of $114K, Loss Narrows

EWSB Bancorp reported a net loss of $113,655 for the third quarter of 2026, an improvement from a $3.34 million loss in the prior year period which was impacted by a large tax provision. The company strengthened its capital position during the quarter through a stock offering and the issuance of preferred shares, totaling approximately $774,829 in net proceeds.

Key figure
Net loss $114K
4:02 PM ET 10-Q
Financial Results Vireo Growth Inc. VREOF

Vireo Growth Q3 2026 Results: Net Loss of $24M, Loss Narrows

Vireo Growth Inc. reported a significant revenue increase to $253.7 million for the quarter ended September 30, 2026, compared to $91.7 million in the prior year, driven by multiple acquisitions including Eaze, Hawthorne, and C21. Despite higher gross profits, the company recorded a net loss of $24.0 million for the quarter, impacted by substantial current income tax expenses and transaction-related costs.

Key figure
Net loss $24M
4:02 PM ET 10-Q
Financial Results Lifeway Foods, Inc. LWAY

Lifeway Foods Q3 2026 Results: Net Income $260K, Down 92.6% YoY

Lifeway Foods reported a significant increase in net sales to $197.7 million for the nine months ended September 30, 2026, compared to $157.1 million in the prior year. However, net income decreased to $5.1 million from $11.3 million year-over-year, primarily driven by higher cost of goods sold and increased selling expenses, including a substantial rise in advertising costs.

Key figure
Net income $260K · -92.6% YoY
4:02 PM ET 8-K
Financial Results Smith Micro Software, Inc. SMSI

Smith Micro Software Financial Results

Smith Micro Software reported Q3 2026 revenue of $5.0 million, a 16% sequential increase and a year-over-year improvement from $4.3 million. The company achieved a five-year high gross margin of 81.6% and significantly narrowed its GAAP net loss to $1.7 million compared to $5.2 million in the prior year's quarter.

Term
Q3 2026

“Our third quarter marked our third consecutive quarter of sequential revenue growth as we continued to build on the momentum established in the first half of the year. Revenue increased 16% sequentially and gross margin rose to 81.6%, a five-year high.”

William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro

“Our pipeline continues to grow and yield high-quality opportunities, and I am confident in our ability to translate this momentum into long-term growth.”

William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro
4:02 PM ET 8-K
Financial Results Andersen Group Inc. ANDG

Andersen Group Financial Results

Andersen Group reported Q3 2026 revenue of $337.3 million, an 18.7% increase year-over-year, driven by broad-based growth across all service lines and geographic regions. The company reported GAAP net income of $68.0 million and introduced full-year 2027 revenue guidance of $1.275 billion to $1.325 billion.

4:02 PM ET Form 4
Insider Selling Clean Energy Fuels Corp. CLNE

Clean Energy Fuels Director Andrew J. Littlefair Sells $184K of Stock

Andrew J. Littlefair, Director, sold 100,000 shares of Clean Energy Fuels Corp. at $1.84 a share, worth $184K in total on Nov 10, 2026. Shares held after the trade: 1,882,832 (-5.0%).

Value
$184K
Shares
100,000
Price
$1.84
Role
Director
Holding change
-5.0%
Trade date
Nov 10, 2026
4:02 PM ET 10-Q
Financial Results Legacy Education Inc. LGCY

Legacy Education Q1 2026 Results: Net Income $869K, Down 60.3% YoY

Legacy Education Inc. reported total assets of $86.9 million as of September 30, 2026, compared to $78.5 million at the end of the prior fiscal year. The company's stockholders' equity increased to $54.0 million, driven by growth in retained earnings and additional paid-in capital.

Key figure
Net income $869K · -60.3% YoY
4:02 PM ET 10-Q
Financial Results Advanced Biomed Inc. ADVB

Advanced Biomed Q1 2026 Results: Net Loss of $989K, Loss Widens

Advanced Biomed Inc. reported a net loss of $989,054 for the quarter ended September 30, 2026, as it transitioned from biotechnology to AI and financial software activities. The company's cash position decreased to $213,995, and it recognized a significant provision for credit losses of $612,636 during the period.

Key figure
Net loss $989K
4:02 PM ET Form 4
Insider Buying Alnylam Pharmaceuticals, Inc. ALNY

Alnylam Pharmaceuticals Insider Amy W. Schulman Buys $300K of Stock

Amy W. Schulman bought 1,910 shares of Alnylam Pharmaceuticals, Inc. at $156.82 a share, worth $300K in total on Nov 9, 2026. Shares held after the trade: 25,959 (+7.9%).

Value
$300K
Shares
1,910
Price
$156.82
Holding change
+7.9%
Trade date
Nov 9, 2026
4:02 PM ET Form 4
Insider Selling Applied Optoelectronics, Inc. AAOI

Applied Optoelectronics CFO Stefan J. Murry Sells $195K of Stock

Stefan J. Murry, CFO, sold 4,000 shares of Applied Optoelectronics, Inc. at $48.83 a share, worth $195K in total on Nov 10, 2026. Shares held after the trade: 353,223 (-1.1%).

Value
$195K
Shares
4,000
Price
$48.83
Role
CFO
Holding change
-1.1%
Trade date
Nov 10, 2026
4:02 PM ET 10-Q
Financial Results Pluri Inc. PLUR

Pluri Q1 2026 Results: Net Loss of $10.4M, Loss Widens

Pluri Inc. reported a significant increase in net loss to $15.39 million for the quarter ended September 30, 2026, primarily driven by a $10.9 million charge for acquired in-process research and development related to the Fishway Transaction. Despite the loss, revenues grew to $759,000 compared to $316,000 in the prior year, and the company successfully raised capital through share issuances and a SAFE agreement.

Key figure
Net loss $10.4M
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Executive Chairman Jurgi Camblong Sells $65.9K of Stock

Jurgi Camblong, Executive Chairman, sold 8,500 shares of SOPHiA Genetics SA at $7.76 a share, worth $65.9K in total on Nov 10, 2026. Shares held after the trade: 3,378,650 (-0.3%).

Value
$65.9K
Shares
8,500
Price
$7.76
Role
Executive Chairman
Holding change
-0.3%
Trade date
Nov 10, 2026
4:02 PM ET 10-Q
Financial Results Avalanche Treasury Corp AVAT

Avalanche Treasury Q3 2026 Results: Turns Profitable, Net Income $54.6M

Avalanche Treasury Corporation reported a net loss of $16.8 million for the nine months ended September 30, 2026, despite a profitable third quarter with net income of $54.6 million driven by changes in the fair value of digital assets. The company's balance sheet shows significant holdings in AVAX and USDC, with total assets decreasing from $190.9 million at year-end 2025 to $151.9 million.

Key figure
Net income $54.6M
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Insider Kathy L. Hibbs Sells $48.5K of Stock

Kathy L. Hibbs sold 6,250 shares of SOPHiA Genetics SA at $7.76 a share, worth $48.5K in total on Nov 10, 2026. Shares held after the trade: 90,742 (-6.4%).

Value
$48.5K
Shares
6,250
Price
$7.76
Holding change
-6.4%
Trade date
Nov 10, 2026
4:02 PM ET 8-K
Executive Compensation Frontdoor, Inc. FTDR

Frontdoor Executive Compensation

Frontdoor, Inc. has appointed Mary Hopkins as Vice President, Controller and Chief Accounting Officer, effective December 14, 2026. Her compensation package includes an annual base salary of $415,000, a 50% target bonus, a $250,000 sign-on cash bonus, and a $250,000 sign-on equity grant in restricted stock units.

Counterparty
Mary Hopkins
4:02 PM ET 8-K
Other 8-K Filing JAB Acquisition Corp I ATLQ

Atlantic Acquisition Corp I Other 8-K Filing

Atlantic Acquisition Corp I (formerly JAB Acquisition Corp I) held an Extraordinary General Meeting where shareholders approved a formal name change and the adoption of amended and restated Memorandum and Articles of Association. The name change became effective on November 9, 2026, and the company's trading symbols on Nasdaq remain ATLQ, ATLQU, ATLQW, and ATLQR.

4:02 PM ET Form 4
Insider Selling TheRealReal, Inc. REAL

TheRealReal CFO Gopal Ajay Madan Sells $1.04M of Stock

Gopal Ajay Madan, CFO, sold 71,027 shares of TheRealReal, Inc. at $14.65 a share, worth $1.04M in total on Nov 11, 2026. Shares held after the trade: 1,037,833 (-6.4%).

Value
$1.04M
Shares
71,027
Price
$14.65
Role
CFO
Holding change
-6.4%
Trade date
Nov 11, 2026
4:02 PM ET 10-Q
Financial Results Bank of the James Financial Group Inc BOTJ

Bank of the James Financial Group Q3 2026 Results: Net Income $3.32M, Up 20.7% YoY

Bank of the James Financial Group reported net income of $9.34 million for the first nine months of 2026, a significant increase from $6.30 million in the same period of 2025, driven by higher net interest income. Total assets grew to $1.06 billion, though stockholders' equity slightly decreased to $78.4 million due to an increase in accumulated other comprehensive loss from unrealized losses on available-for-sale securities.

Key figure
Net income $3.32M · +20.7% YoY
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CLO Well Daan Van Sells $10.5K of Stock

Well Daan Van, CLO, sold 1,411 shares of SOPHiA Genetics SA at $7.44 a share, worth $10.5K in total on Nov 9, 2026. Shares held after the trade: 331,305 (-0.4%).

Value
$10.5K
Shares
1,411
Price
$7.44
Role
CLO
Holding change
-0.4%
Trade date
Nov 9, 2026
4:02 PM ET 10-Q
Financial Results Noble Romans Inc NROM

Noble Romans Q3 2026 Results: Net Income $84.7K, Down 84.7% YoY

Noble Roman's reported total revenue of $11.27 million for the nine months ended September 30, 2026, a slight increase from the prior year, though net income decreased from $882,839 to $396,072. The company successfully refinanced its debt, moving the majority of its senior loan obligations from current to long-term liabilities.

Key figure
Net income $84.7K · -84.7% YoY
4:02 PM ET 8-K
Financial Results Arrowhead Pharmaceuticals, Inc. ARWR

Arrowhead Pharmaceuticals Financial Results

Arrowhead Pharmaceuticals reported financial results for its fiscal year ended September 30, 2026, highlighting the commercial launch of REDEMPLO for familial chylomicronemia syndrome (FCS). The company reported 950 cumulative prescriptions since launch and announced that the FDA granted plozasiran entry into the STAR pilot program for severe hypertriglyceridemia, qualifying it for a 6-month priority review.

Term
FY2026

“Arrowhead has fundamentally changed over the past 12 months. Where there was once a company that relied solely on great scientific promise, there is now a company that is beginning to translate promise into real patient outcomes and the potential for durable shareholder value growth.”

Christopher Anzalone, Ph.D., President and CEO

“I believe we approach 2027 with the strongest combination of near-term commercial opportunity and scientific capability in our history.”

Christopher Anzalone, Ph.D., President and CEO
4:01 PM ET 10-Q
Financial Results Kidz AI Inc. KIDZ

Kidz AI Q3 2026 Results: Net Loss of $654K

KIDZ AI Inc. reported a significant net loss of $7.34 million for the nine months ended September 30, 2026, compared to a $1.64 million loss in the prior year, driven by a $3.38 million fair value loss on crypto assets. Despite the loss, the company significantly strengthened its balance sheet through $10.74 million in private placement capital contributions and the conversion of $9.46 million in debt into equity.

Key figure
Net loss $654K
4:01 PM ET 10-K
Financial Results Hartford Creative Group, Inc. HFUS

Hartford Creative Group FY 2026 Results: Net Income $642K, Down 41.6% YoY

Hartford Creative Group reported total revenues of $2,744,029 for fiscal 2026, a 35% increase driven by its advertising agency business, though net income fell 42% to $641,767 due to a significant credit loss expense and higher income taxes. The company is pivoting toward a mini-drama platform (YYYS App) and is pursuing an uplisting to the Nasdaq Capital Market to fund its estimated $2.0 million in upcoming capital requirements.

Key figure
Net income $642K · -41.6% YoY
4:01 PM ET Form 4
Insider Buying Drilling Tools International Corp DTI

Drilling Tools International Director Jack D. Furst Buys $23.8K of Stock

Jack D. Furst, Director, bought 14,441 shares of Drilling Tools International Corp at $1.65 a share, worth $23.8K in total on Nov 11, 2026. Shares held after the trade: 77,920 (+22.7%).

Value
$23.8K
Shares
14,441
Price
$1.65
Role
Director
Holding change
+22.7%
Trade date
Nov 11, 2026
4:01 PM ET 10-Q
Financial Results Axt Inc AXTI

Axt Q3 2026 Results: Turns Profitable, Net Income $25.7M

AXT, Inc. reported a significant revenue increase to $73.4 million for the third quarter of 2026, up from $28.0 million in the prior year, driven by improved gross margins and operational performance. The company swung to a net income of $25.7 million for the quarter compared to a net loss of $1.9 million in 2025, while its cash position strengthened substantially to $485.5 million following a major common stock issuance.

Key figure
Net income $25.7M
4:01 PM ET 10-Q
Financial Results Akari Therapeutics Plc AKTX

Akari Therapeutics Q3 2026 Results: Net Loss of $4.84M, Loss Narrows

For the nine months ended September 30, 2026, Akari Therapeutics reported a net loss of $24.1 million, significantly higher than the $12.0 million loss in the prior year period, primarily driven by $12.1 million in impairment losses on goodwill and intangible assets. The company maintained a cash balance of $5.7 million and saw its total shareholders' equity decrease from $28.3 million to $17.5 million during the period.

Key figure
Net loss $4.84M
4:01 PM ET 10-Q
Financial Results Intellinetics, Inc. INLX

Intellinetics Q3 2026 Results: Net Loss of $239K, Loss Narrows

Intellinetics, Inc. reported a decrease in total assets from $17.3 million at year-end 2025 to $16.7 million as of September 30, 2026. The company's accumulated deficit increased to $26.0 million, while deferred revenues grew significantly to $4.1 million, reflecting shifts in its software-as-a-service and recurring revenue model.

Key figure
Net loss $239K
4:01 PM ET 10-Q
Financial Results EagleRock Land, LLC EROK

EagleRock Land Q3 2026 Results: Net Income $2.11M

EagleRock Land, LLC is an emerging growth company focused on surface, resource, and water infrastructure assets in the Permian Basin. The filing highlights its recent initial public offering in May 2026 and outlines key operational risks including customer concentration, commodity price volatility, and reliance on surface use agreements.

Key figure
Net income $2.11M
4:01 PM ET 10-Q
Financial Results Yale Transaction Finders, Inc. YTFD

Yale Transaction Finders Q3 2026 Results: Net Loss of $5.61K, Loss Narrows

Yale Transaction Finders, Inc. is a shell company with no revenue, reporting a net loss of $23,521 for the nine months ended September 30, 2026. The company faces substantial doubt about its ability to continue as a going concern, characterized by an accumulated deficit of $1,421,109 and reliance on related-party financing.

Key figure
Net loss $5.61K
4:01 PM ET Form 4
Insider Selling TheRealReal, Inc. REAL

TheRealReal CAO Steve Ming Lo Sells $299K of Stock

Steve Ming Lo, CAO, sold 20,070 shares of TheRealReal, Inc. at $14.90 a share, worth $299K in total on Nov 10, 2026. Shares held after the trade: 156,840 (-11.3%).

Value
$299K
Shares
20,070
Price
$14.90
Role
CAO
Holding change
-11.3%
Trade date
Nov 10, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.